The frequency of B cells after stimulation with the Spike 1 antigen was based on the classical biomarker, CD19, while previously excluding those expressing CD3, CD16, CD56, and CD14, as shown in the representative analysis strategy of a patient with acute COVID-19 (Figure 2A). The gene discussed is NCAM1; the disease is COVID-19.